All In Biotech

Free tool

FAERS Monitor: Evenity

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761062 or its brand name (Evenity, Romosozumab-Aqqg). Reports on generic versions are filed under their own applications.

Reports

14,247

Serious

8,363

59% of reports

Hospitalization

3,477

Death reported

759

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fall844
  • fracture676
  • arthralgia670
  • injection site pain592
  • off label use528
  • headache498
  • hospitalisation481
  • bone density abnormal463
  • product storage error357
  • pain344
  • pain in extremity340
  • spinal fracture335
  • death333
  • femur fracture314
  • injection site swelling312

Reports by year received

View as table
YearReports
20181
2019776
20201,210
20211,454
20222,389
20232,110
20242,143
20252,097
20262,067

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,912 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bone density abnormalSignal463208.6189.583,648
fractureSignal67654.650.734,307
spinal fractureSignal33525.122.57,599
femur fractureSignal31415.113.54,088
product storage errorSignal3576.05.51,497
injection site swellingSignal3126.05.41,304
hospitalisationSignal4814.64.21,372
fallSignal8443.83.51,723
injection site painSignal5922.92.6720
arthralgiaSignal6702.42.2545
pain in extremity3401.71.5100
headache4981.21.113
off label use5280.90.87
pain3440.80.713
death3330.60.5112

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.